272 related articles for article (PubMed ID: 10845752)
21. Longitudinal incidence of tuberculosis in South-East Asian refugees after re-settlement.
MacIntyre CR; Plant AJ
Int J Tuberc Lung Dis; 1999 Apr; 3(4):287-93. PubMed ID: 10206498
[TBL] [Abstract][Full Text] [Related]
22. [Tuberculosis in asylum seekers in The Netherlands].
Kuyvenhoven JV; Lambregts-van Weezenbeek CS; Année-van Bavel JA
Ned Tijdschr Geneeskd; 1997 Mar; 141(12):581-4. PubMed ID: 9190525
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil.
Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW
Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247
[TBL] [Abstract][Full Text] [Related]
24. The cost of intensified case finding and isoniazid preventive therapy for HIV-infected patients in Battambang, Cambodia.
Sutton BS; Arias MS; Chheng P; Eang MT; Kimerling ME
Int J Tuberc Lung Dis; 2009 Jun; 13(6):713-8. PubMed ID: 19460246
[TBL] [Abstract][Full Text] [Related]
25. DOT and timely treatment completion among Asian-born immigrant tuberculosis patients.
Liu SY; Li JH; Schluger NW
Int J Tuberc Lung Dis; 2005 Aug; 9(8):884-9. PubMed ID: 16104635
[TBL] [Abstract][Full Text] [Related]
26. Risk factors for development of tuberculosis after isoniazid chemoprophylaxis in human immunodeficiency virus-infected patients.
Casado JL; Moreno S; Fortún J; Antela A; Quereda C; Navas E; Moreno A; Dronda F
Clin Infect Dis; 2002 Feb; 34(3):386-9. PubMed ID: 11753825
[TBL] [Abstract][Full Text] [Related]
27. Mini epidemic of isoniazide resistant TB in rural TN: a need for supervised preventive therapy.
Mehta J; Keith R; Al Hasan M; Ryland B; Roy T
Tenn Med; 2009 Aug; 102(8):41-4. PubMed ID: 19691201
[TBL] [Abstract][Full Text] [Related]
28. Improving tuberculosis therapy completion after jail: translation of research to practice.
White MC; Tulsky JP; Menendez E; Arai S; Goldenson J; Kawamura LM
Health Educ Res; 2005 Apr; 20(2):163-74. PubMed ID: 15314035
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
[TBL] [Abstract][Full Text] [Related]
30. Preventive therapy for tuberculosis in Western Australia.
Pang SC; Harrison RH; Brearley J; Jegathesan V; Clayton AS
Int J Tuberc Lung Dis; 1998 Dec; 2(12):984-8. PubMed ID: 9869113
[TBL] [Abstract][Full Text] [Related]
31. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study.
Spyridis NP; Spyridis PG; Gelesme A; Sypsa V; Valianatou M; Metsou F; Gourgiotis D; Tsolia MN
Clin Infect Dis; 2007 Sep; 45(6):715-22. PubMed ID: 17712755
[TBL] [Abstract][Full Text] [Related]
32. [A-cohort study on the standard short-course chemotherapy program for drug resistant tuberculosis in the rural counties in Eastern China].
Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jun; 29(6):540-4. PubMed ID: 19040032
[TBL] [Abstract][Full Text] [Related]
33. High success rate of TB treatment among Bhutanese refugees in Nepal.
Bam TS; Enarson DA; Hinderaker SG; Chapman RS
Int J Tuberc Lung Dis; 2007 Jan; 11(1):54-8. PubMed ID: 17217130
[TBL] [Abstract][Full Text] [Related]
34. Tuberculosis treatment default among Brazilian children.
Oliveira VL; da Cunha AJ; Alves R
Int J Tuberc Lung Dis; 2006 Aug; 10(8):864-9. PubMed ID: 16898370
[TBL] [Abstract][Full Text] [Related]
35. Cost-effectiveness of including tuberculin skin testing in an IPT program for HIV-infected persons in Uganda.
Shrestha RK; Mugisha B; Bunnell R; Mermin J; Hitimana-Lukanika C; Odeke R; Madra P; Adatu F; Blandford JM
Int J Tuberc Lung Dis; 2006 Jun; 10(6):656-62. PubMed ID: 16776453
[TBL] [Abstract][Full Text] [Related]
36. Completion of tuberculosis therapy for patients reported in the United States in 1993.
Bloch AB; Cauthen GM; Simone PM; Kelly GD; Dansbury KG; Castro KG
Int J Tuberc Lung Dis; 1999 Apr; 3(4):273-80. PubMed ID: 10206496
[TBL] [Abstract][Full Text] [Related]
37. Thai drug-resistant tuberculosis predictive scores.
Boonsarngsuk V; Tansirichaiya K; Kiatboonsri S
Singapore Med J; 2009 Apr; 50(4):378-84. PubMed ID: 19421681
[TBL] [Abstract][Full Text] [Related]
38. Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.
Ormerod LP
Br Med Bull; 2005; 73-74():17-24. PubMed ID: 15956357
[TBL] [Abstract][Full Text] [Related]
39. Tuberculosis in South-East Asian refugees after resettlement--can prevention be improved by better policy and practice?
MacIntyre CR; Plant AJ
Prev Med; 1998; 27(6):815-20. PubMed ID: 9922063
[TBL] [Abstract][Full Text] [Related]
40. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
Nolan CM; Goldberg SV
Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
